Skip to main content

Table 1 Participant characteristics

From: Standardising the measurement of physical activity in people receiving haemodialysis: considerations for research and practice

 

Total (n = 77)

Age (years)a

56 ± 14

Sex n (%)

 Female

28 (36)

 Male

49 (64)

Country n (%)

 British

  White British

26 (34)

  Indian

17 (22)

  Any other Asian background

1 (1)

  Caribbean

1 (1)

  Any other black background

1 (1)

 Chinese

31 (40)

Diagnosis n (%)

 Glomerulonephritis

31 (40)

 Diabetic Nephropathy

11 (14)

 Renal vascular disease

9 (12)

 Aetiology unknown

8 (10)

 Polycystic Kidney Disease

7 (9)

 Chronic Pyelonephritis

5 (7)

 Membranous nephropathy

2 (3)

 Light chain deposition disease

1 (1)

 Systemic Lupus Erythematosus

1 (1)

 Cyclosporine A Nephropathy

1 (1)

 Other genetic kidney disease

1 (1)

Time on HD (months)

40 (19–72)

BMI (kg/m2)

24.00 (21.30–28.40)

Charlson comorbidity index

3 (2–5)

Previous transplant n (%)

 No

68 (88)

 Yes

9 (12)

Haemoglobina (g/dl)

11.57 ± 1.48

Albumina (g/l)

39.19 ± 4.49

CRP (mg/L)

5.00 (3.75–7.00)

Use of ESA n (%)

 Yes

69 (90)

 No

8 (10)

  1. Data reported as median (interquartile range) unless stated. amean and SD. Abbreviations: BMI Body mass index, CRP C-Reactive Protein, ESA Erythropoietin stimulating agent, HD haemodialysis